AXIOS January 17, 2024
Rebecca Falconer

The Apple Watch Series 9 and Ultra 2 will go on sale in U.S. stores Thursday morning without their blood oxygen features, the company announced.

Driving the news: The announcement came after a federal appeals court ruled Wednesday that Apple couldn’t import wearables with this feature into the country while the company appeals the U.S. International Trade Commission’s finding that the devices infringe patents.

  • Apple had asked the court to extend a stay allowing the import of the devices while the company appeals USITC’s decision finding that the world’s largest smartwatch seller had infringed two patents owned by Masimo Corporation and Cercacor Laboratories, which the commission said became final on Dec. 26.

What’s happening: “The Apple Watch Series...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Technology, Wearables
Related Articles:
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article